News
HSBC lowered its earnings forecasts for 2025-27, noting that higher tariffs and ongoing cost pressures are likely to limit ...
Marks & Spencer (OTC: MAKSY) posted a 6.7% year-on-year rise in food sales during the 12 weeks to Aug. 9, with growth recovering as the impact of an April cyberat ...
For the second quarter, Kingsoft Cloud posted a loss of RMB0.11 per share, substantially better than the analyst estimate of a RMB0.97 loss. Revenue reached RMB2.35 billion, surpassing the consensus ...
Investing.com -- JP Morgan upgraded shares of fintech lender Upstart (NASDAQ: UPST) to Overweight, saying improving consumer ...
Bank of America cut its rating for Avis Budget (NASDAQ: CAR) Group to Underperform from Buy in a note on Wednesday, warning ...
Investing.com -- JPMorgan (NYSE: JPM) could regain the top spot in U.S. credit cards if it acquires Goldman Sachs’ Apple Card ...
President Donald Trump called for Federal Reserve Governor Lisa Cook to "resign, now!!!" on Wednesday, citing a Bloomberg ...
“HPE is well positioned to drive upside in the Jul-qtr and through the near-term following the closing of its Juniper ...
U.S. stock futures slipped slightly lower Wednesday, as investors digested quarterly results from the retail sector ahead of ...
Small caps and homebuilders are the most at risk if the Federal Reserve strikes a hawkish tone at Jackson Hole, according to ...
Investing.com -- Hertz Global Holdings (NASDAQ: HTZ) stock surged 12% Wednesday morning while Carvana (NYSE: CVNA) shares fell 5.5% following news that Hertz will begin selling its pre-owned vehicles ...
Investing.com -- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stock surged 23% after the FDA lifted a clinical hold on the company’s pivotal Phase 2 trial of RP-A501 for the treatment of Danon disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results